Autopsy report · NCT03872505
Pre-operAtive Non-Anthracycline Chemotherapy, Durvalumab +/- RAdiation Therapy in Triple Negative Breast Cancer
Cause of deathFunding or business
“lack of funding”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Phase 2
- Sponsor
- Cedars-Sinai Medical Center
- Sponsor type
- University, hospital or other
- Conditions
- Breast Cancer; Triple Negative Breast Cancer
- Interventions
- Durvalumab; Radiation Therapy; Carboplatin; Paclitaxel
- Participants
- 0
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.